Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Chronic Kidney Disease-Mineral and Bone Disorder

Chronic Kidney Disease-Mineral and Bone Disorder

Part of Malnutrition

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Chronic Kidney Disease-Mineral and Bone Disorder

2 trials tracked for Chronic Kidney Disease-Mineral and Bone Disorder.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 1 Other / NA 1
  1. Phase 2 The Effect of Etelcalcetide on CKD-MBD Completed
  2. N/A Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
CKD-MBD medication titration is associated with serum calcium, phosphorus, and parathyroid hormone levels
Nephrology RCT
CKD-MBD medication titration is associated with serum calcium, phosphorus, and parathyroid hormone levels Doctors Titrate Kidney Medications Based on Specific Lab Results
This observational study of 23,549 patients on hemodialysis found that titration patterns for vitamin D sterols and calcimimetics were assoc…
New data shows that doctors adjust kidney medications based on specific lab markers like calcium and phosphorus levels for thousands of dial…
medRxiv Aug 4, 2026
Systematic Review and Meta-Analysis Links α-Klotho to Frailty and Bone Health in Aging
Nephrology Meta-analysis
Systematic Review and Meta-Analysis Links α-Klotho to Frailty and Bone Health in Aging Higher Alpha-Klotho Levels Mean Less Frailty And Better Bones
This systematic review and meta-analysis of 109 studies found that higher circulating α-Klotho levels were associated with lower odds of fra…
New research shows that higher Alpha-Klotho levels protect against frailty and bone loss, offering hope for better aging outcomes.
Apr 30, 2026
Systematic review links gut microbiota dysbiosis to CKD-MBD, RA, OA, and OP pathogenesis
Nephrology Sys. Review
Systematic review links gut microbiota dysbiosis to CKD-MBD, RA, OA, and OP pathogenesis Your gut holds the key to your bone health
This systematic review examines the role of gut microbiota dysbiosis in chronic kidney disease-mineral and bone disorder (CKD-MBD), rheumato…
Gut bacteria directly influence bone strength and kidney health, yet current treatments ignore the digestive system where the real problem s…
Frontiers Apr 13, 2026